Contact Us
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is now a finalist in these awards for the third straight year.
UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.

The 2024 Citeline Awards have recognized UBC as a finalist in the category of Excellence in Use of Real-World Data/Evidence. This is now the third year in a row that UBC has been named a finalist for these awards.

The study UBC is recognized for includes tokenizing the data of pragmatic trial participants and linkages to 16 real-world data sources. The goal is to inform understanding of the patient journey before and after enrollment, as well as assess medication effectiveness and safety risks against usual care.

As a leader in modernized study designs that generate critical real-world evidence of safety and effectiveness, UBC is proud to be recognized for our work on this study design and execution. If you would like to learn more about how UBC incorporates the right mix of tools and techniques to efficiently and effectively achieve your study aims, get in touch with us here.

Other Recent Posts

View More
Featured Image
Press
January 27, 20263 min read

UBC Appoints Dr. Massoud Toussi as Vice President, Real World Evidence

UBC welcomes Massoud Toussi as its new Vice President of Real-World Evidence. Toussi brings over 20 years of experience spanning pharma, CROs, and regulatory work. He's authored more than 50 publications and contributed to scientific standards through ENCePP, ISPE, ISPOR, and other key organizations.
The acquisition strengthens UBC’s leadership in evidence generation offerings with globally recognized expertise in HEOR, medical affairs and market access.
Press
January 6, 20264 min read

UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities

United BioSource LLC (UBC) has acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical and economic analysis.
nanotechnology and abstract graphene structures
Press
November 20, 20256 min read

Datavant and UBC Partner to Transform Observational Research and Patient Access for Biopharmaceutical Sponsors

Datavant and United BioSource Corporation (UBC) have joined forces to transform late-phase research and patient access programs for biopharmaceutical sponsors. By combining Datavant’s privacy-first data connectivity with UBC’s expertise in specialty therapies, the partnership introduces two new offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. These solutions aim to accelerate evidence generation, improve patient outcomes, and set a new standard for real-world research and access.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.